European society of contraception statement on contraception in obese women.
The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.
['Merki-Feld|Gabriele S|GS|', 'Skouby|Sven|S|', 'Serfaty|David|D|', 'Lech|Medard|M|', 'Bitzer|Johannes|J|', 'Crosignani|Pier Giorgio|PG|', 'Cagnacci|Angelo|A|', 'Sitruk-Ware|Regine|R|']
D003267:Contraception D044363:Contraception, Postcoital D003271:Contraceptive Agents, Female D019049:Developed Countries D005060:Europe D005260:Female D006801:Humans D007436:Intrauterine Devices, Medicated D009765:Obesity D050177:Overweight D011247:Pregnancy D012955:Societies, Medical D054556:Venous Thromboembolism
Obesity Contraceptive failure Depo-medroxyprogesterone Efficacy Hormonal contraception Progestin-only contraception Thromboembolic risk Weight